Latest News and Press Releases

Cohen Milstein continues lead plaintiff Search for Zenas BioPharma (ZBIO) securities fraud class action. Contact Molly Bowen, Esq. at 1 (202) 408-4600.

Cohen Milstein reminds Zenas BioPharma (ZBIO) investors of an opportunity to lead a securities fraud class action. Lead plaintiff deadline - June 16, 2025.

Cohen Milstein seeks Zenas BioPharma (ZBIO) investors to join and/or lead class action to hold Zenas BioPharma accountable for IPO-related fraud.

Cohen Milstein Encourages Zenas BioPharma Investors Who Lost Money Following IPO Stock Collapse to Call Firm to Potentially Join or Lead Class Action.

SAN DIEGO, Aug. 27, 2024 (GLOBE NEWSWIRE) -- A class action lawsuit has been filed on behalf of purchasers or acquirers of Moderna, Inc. (NASDAQ: MRNA) (“Moderna” or the “Company”) securities...

SAN DIEGO, Aug. 15, 2024 (GLOBE NEWSWIRE) -- A class action lawsuit has been filed on behalf of purchasers or acquirers of DXC Technology Company (NYSE: DXC) (“DXC” or the “Company”) common stock...

PERION NETWORK LTD. (NASDAQ: $PERI) - Investor Alert: DiCello Levitt LLP Encourages Investors to Retain Counsel Before Class Action Deadline.

DiCello Levitt announces that purchasers of Lincoln National Corporation common stock have until June 24, 2024 to seek appointment as lead plaintiff

RIVIAN AUTOMOTIVE ALERT: INVESTOR LAWSUIT FILED AGAINST RIVIAN AUTOMOTIVE (NASDAQ: RIVN); JUNE 18, 2024 LEAD PLAINTIFF DEADLINE

ALERT: INVESTOR LAWSUIT FILED AGAINST DOXIMITY, INC. (NYSE: DOCS); JUNE 17, 2024 LEAD PLAINTIFF DEADLINE